假基因的功能及其在癌症疾病中的重要作用

doi:10.16288/j.yczz.2015.01.002

遗传 ›› 2015, Vol. 37 ›› Issue (1): 8-16.doi: 10.16288/j.yczz.2015.01.002

假基因的功能及其在癌症疾病中的重要作用

汤静思, 杨明耀, 李英

四川农业大学,畜禽遗传资源发掘与创新利用四川省重点实验室,成都 611130

收稿日期:2014-09-25 修回日期:2014-10-26 出版日期:2015-01-20 发布日期:2015-01-20
通讯作者: 李英,博士,研究员,研究方向：动物分子进化。E-mail: yingli@sicau.edu.cn E-mail:yingli@sicau.edu.cn
作者简介:汤静思,在读硕士研究生,专业方向：动物分子进化。E-mail：tangjs1115@qq.com 电话：010-64807669;传真：010-64807786; 《遗传》编辑部 2015年1月 10日
基金资助:
四川省“千人计划”,四川省青年基金和四川省高校创新团队计划资助

Functional roles of pseudogenes in cancers

Jingsi Tang, Mingyao Yang, Ying Li

Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province, Sichuan Agricultural University, Chengdu 611130, China

Received:2014-09-25 Revised:2014-10-26 Online:2015-01-20 Published:2015-01-20

摘要/Abstract

摘要： 假基因是一段具有与功能基因相似的DNA序列,但由于存在许多突变以致失去了原有的功能。过去的研究认为假基因是没有功能的DNA片段,是基因组进化过程中产生的噪音。然而,随着分子生物学技术的发展,越来越多的研究证明了假基因具有重要的生物学功能。假基因可与功能基因竞争性结合miRNA,从而调控功能基因的表达;假基因还可产生内源性小干扰RNA抑制功能基因的表达;甚至有的假基因还可以编码具有功能的蛋白质。文章通过假基因的分类、假基因的识别、假基因的功能和假基因与癌症疾病的关系等方面综述了假基因研究的最新进展。

关键词: 假基因, 微小RNA, 小干扰RNA, 反义RNA, 癌症

Abstract: Pseudogene is a DNA fragment with high sequence similarity to the corresponding functional gene. Because of accumulation of multiple mutations, pseudogenes have lost their original functions. Previous studies indicated that pseudogenes are dysfunctional relatives of the corresponding functional genes, and are noises in the process of genome evolution. However, with the development of molecular biotechnologies, more and more studies have demonstrated that pseudogenes possess important biologic functions. For example, some pseudogene could regulate the expression of functional genes by competitively binding to the miRNAs, some could produce endogenous small interference RNAs to negatively regulate the expression of functional genes, and some even could encode functional proteins. In this review, we summarize the recent research progresses of pseudogenes through four aspects: the classification, identification, function, and particularly the roles in cancers.

Key words: pseudogene, miRNA, small interference RNA, antisense RNA, cancer

汤静思, 杨明耀, 李英. 假基因的功能及其在癌症疾病中的重要作用[J]. 遗传, 2015, 37(1): 8-16.

Jingsi Tang, Mingyao Yang, Ying Li. Functional roles of pseudogenes in cancers[J]. HEREDITAS(Beijing), 2015, 37(1): 8-16.

参考文献

[1] Jacq C, Miller JR, Brownlee GG. A pseudogene structure in 5S DNA of Xenopus laevis . Cell , 1977, 12(1): 109-120.
[2] Proudfoot N. Pseudogenes. Nature , 1980, 286(5776): 840-841.
[3] Petrov DA, Hartl DL. Pseudogene evolution and natural selection for a compact genome. J Hered , 2000, 91(3): 221-227.
[4] Podlaha O, Zhang JZ. Pseudogenes and their evolution. Chichester: John Wiley & Sons, 2001.
[5] Zhou BS, Beidler DR, Cheng YC. Identification of antisense RNA transcripts from a human DNA topoisomeraseⅠ pseudogene 1. Cancer Res , 1992, 52(15): 4280-4285.
[6] Korneev SA, Park JH, O'shea M. Neuronal expression of neural nitric oxide synthase (nNOS) protein is suppressed by an antisense RNA transcribed from an NOS pseudogene. J Neurosci , 1999, 19(18): 7711-7720.
[7] Tam OH, Aravin AA, Stein P, Girard A, Murchison EP, Cheloufi S, Hodges E, Anger M, Sachidanandam R, Schultz RM, Hannon GJ. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature , 2008, 453(7194): 534-538.
[8] Poliseno L, Salmena L, Zhang JW, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature , 2010, 465(7301): 1033-1038.
[9] Johnsson P, Ackley A, Vidarsdottir L, Lui WO, Corcoran M, Grandér D, Morris KV. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol , 2013, 20(4): 440-446.
[10] Mighell AJ, Smith NR, Robinson PA, Markham AF. Vertebrate pseudogenes. FEBS Lett , 2000, 468(2-3): 109-114.
[11] Zhang ZD, Frankish A, Hunt T, Harrow J, Gerstein M. Identification and analysis of unitary pseudogenes: historic and contemporary gene losses in humans and other primates. Genome Biol , 2010, 11(3): R26.
[12] Maestre J, Tchenio T, Dhellin O, Heidmann T. mRNA retroposition in human cells: processed pseudogene formation. EMBO J , 1995, 14(24): 6333-6338.
[13] D'errico I, Gadaleta G, Saccone C. Pseudogenes in metazoa: origin and features. Brief Funct Genom Proteom , 2004, 3(2): 157-167.
[14] Vanin EF. Processed pseudogenes: Characteristics and evolution. Annu Rev Genet , 1985, 19(1): 253-272.
[15] Li WH, Gojobori T, Nei M. Pseudogenes as a paradigm of neutral evolution. Nature , 1981, 292(5820): 237-239.
[16] Wang W, Zhang JM, Alvarez C, Llopart A, Long MY. The origin of the Jingwei gene and the complex modular structure of its parental gene, Yellow emperor , in Drosophila melanogaster . Mol Biol Evol , 2000, 17(9): 1294-1301.
[17] Torrents D, Suyama M, Zdobnov E, Bork P. A genome-wide survey of human pseudogenes. Genome Res , 2003, 13(12): 2559-2567.
[18] Li W, Yang W, Wang XJ. Pseudogenes: pseudo or real functional elements? J Genet Genomics , 2013, 40(4): 171-177.
[19] Balakirev ES, Ayala FJ. PSEUDOGENES: Are they “Junk” or functional DNA? Annu Rev Genet , 2003, 37(1): 123-151.
[20] Betrán E, Wang W, Jin L, Long MY. Evolution of the Phosphoglycerate mutase processed gene in human and chimpanzee revealing the origin of a new primate gene. Mol Biol Evol , 2002, 19(5): 654-663.
[21] Zheng DY, Gerstein MB. A computational approach for identifying pseudogenes in the ENCODE regions. Genome Biol , 2006, 7(Suppl. 1): S13.
[22] Zheng DY, Frankish A, Baertsch R, Kapranov P, Reymond A, Choo SW, Lu Y, Denoeud F, Antonarakis SE, Snyder M, Ruan YJ, Wei CL, Gingeras TR, Guigó R, Harrow J, Gerstein MB. Pseudogenes in the ENCODE regions: consensus annotation, analysis of transcription, and evolution. Genome Res , 2007, 17(6): 839-851.
[23] Molineris I, Sales G, Bianchi F, Di Cunto F, Caselle M. A new approach for the identification of processed pseudogenes. J Comput Biol , 2010, 17(5): 755-765.
[24] Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa A, Searle S, Barnes I, Bignell A, Boychenko V, Hunt T, Kay M, Mukherjee G, Rajan J, Despacio-Reyes G, Saunders G, Steward C, Harte R, Lin M, Howald C, Tanzer A, Derrien T, Chrast J, Walters N, Balasubramanian S, Pei BK, Tress M, Rodriguez JM, Ezkurdia I, Van Baren J, Brent M, Haussler D, Kellis M, Valencia A, Reymond A, Gerstein M, Guigó R, Hubbard TJ. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res , 2012, 22(9): 1760-1774.
[25] Pei BK, Sisu C, Frankish A, Howald C, Habegger L, Mu XJ, Harte R, Balasubramanian S, Tanzer A, Diekhans M, Reymond A, Hubbard TJ, Harrow J, Gerstein MB. The GENCODE pseudogene resource. Genome Biol , 2012, 13(9): R51.
[26] Kalyana-Sundaram S, Kumar-Sinha C, Shankar S, Robinson DR, Wu YM, Cao XH, Asangani IA, Kothari V, Prensner JR, Lonigro RJ, Iyer MK, Barrette T, Shanmugam A, Dhanasekaran SM, Palanisamy N, Chinnaiyan AM. Expressed pseudogenes in the transcriptional landscape of human cancers. Cell , 2012, 149(7): 1622-1634.
[27] Korneev SA, Kemenes I, Bettini NL, Kemenes G, Staras K, Benjamin PR, O'shea M. Axonal trafficking of an antisense RNA transcribed from a pseudogene is regulated by classical conditioning. Sci Rep , 2013, 3: 1027.
[28] Rutnam ZJ, Du WW, Yang WN, Yang XL, Yang BB. The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs. Nat Commun , 2014, 5: 2914.
[29] Borrmann L, Wilkening S, Bullerdiek J. The expression of HMGA genes is regulated by their 3 ' UTR. Oncogene , 2001, 20(33): 4537-4541.
[30] Chiefari E, Iiritano S, Paonessa F, Le Pera I, Arcidiacono B, Filocamo M, Foti D, Liebhaber SA, Brunetti A. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes. Nat Commun , 2010, 1: 40.
[31] Watanabe T, Totoki Y, Toyoda A, Kaneda M, Kuramochi-Miyagawa S, Obata Y, Chiba H, Kohara Y, Kono T, Nakano T, Surani MA, Sakaki Y, Sasaki H. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature , 2008, 453(7194): 539-543.
[32] Chan WL, Yuo CY, Yang WK, Hung SY, Chang YS, Chiu CC, Yeh KT, Huang HD, Chang JG. Transcribed pseudogene ψPPM1K generates endogenous siRNA to suppress oncogenic cell growth in hepatocellular carcinoma. Nucleic Acids Res , 2013, 41(6): 3734-3747.
[33] Eichenlaub MP, Ettwiller L. De novo genesis of enhancers in vertebrates. PLoS Biol , 2011, 9(11): e1001188.
[34] Dierick HA, Mercer JFB, Glover TW. A phosphoglycerate mutase brain isoform (PGAM1 ) pseudogene is localized within the human Menkes disease gene (ATP7A ). Gene , 1997, 198(1-2): 37-41.
[35] Fishman GI, Eddy RL, Shows TB, Rosenthal L, Leinwand LA. The human connexin gene family of gap junction proteins: distinct chromosomal locations but similar structures. Genomics , 1991, 10(1): 250-256.
[36] Kandouz M, Bier A, Carystinos GD, Alaoui-Jamali MA, Batist G. Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene , 2004, 23(27): 4763-4770.
[37] Porter KA, Duffy EB, Nyland P, Atianand MK, Sharifi H, Harton JA. The CLRX. 1/NOD24 (NLRP2P) pseudogene codes a functional negative regulator of NF-κB, pyrin-only protein 4. Genes Immun , 2014, 15(6): 392-403.
[38] Zheng DY, Gerstein MB. The ambiguous boundary between genes and pseudogenes: the dead rise up, or do they? Trends Genet , 2007, 23(5): 219-224.
[39] Han L, Yuan Y, Zheng SY, Yang Y, Li J, Edgerton ME, Diao LX, Xu YX, Verhaak RGW, Liang H. The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes. Nat Commun , 2014, 5: 3963.
[40] Lin H, Shabbir A, Molnar M, Lee T. Stem cell regulatory function mediated by expression of a novel mouse Oct4 pseudogene. Biochem Biophys Res Commun , 2007, 355(1): 111-116.
[41] Zhao SD, Yuan QH, Hao HB, Guo YJ, Liu SM, Zhang YM, Wang JL, Liu HJ, Wang FW, Liu K, Ling EA, Hao AJ. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma. J Pathol , 2011, 223(5): 672-682.
[42] Redshaw Z, Strain AJ. Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression. J Negat Results Biomed , 2010, 9(1): 2.
[43] Guo XP, Tang YM. OCT4 pseudogenes present in human leukemia cells. Clin Exp Med , 2012, 12(4): 207-216.
[44] Kastler S, Honold L, Luedeke M, Kuefer R, Möller P, Hoegel J, Vogel W, Maier C, Assum G. POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma. Prostate , 2010, 70(6): 666-674.
[45] Poliseno L. Pseudogenes: Newly discovered players in human cancer. Sci Signal , 2012, 5(242): re5.
[46] Wang L, Guo ZY, Zhang R, Xin B, Chen R, Zhao J, Wang T, Wen WH, Jia LT, Yao LB, Yang AG. Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma. Carcinogenesis , 2013, 34(8): 1773-1781.
[47] Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov , 2011, 1(5): 391-407.
[48] Han YJ, Ma SF, Yourek G, Park YD, Garcia JGN. A transcribed pseudogene of MYLK promotes cell proliferation. FASEB J , 2011, 25(7): 2305-2312.
[49] Gherman A, Chen PE, Teslovich TM, Stankiewicz P, Withers M, Kashuk CS, Chakravarti A, Lupski JR, Cutler DJ, Katsanis N. Population bottlenecks as a potential major shaping force of human genome architecture. PLoS Genet , 2007, 3(7): e119.
[50] Samaan S, Lichner Z, Ding Q, Saleh C, Samuel J, Streutker C, Yousef GM. Kallikreins are involved in an miRNA network that contributes to prostate cancer progression. Biol Chem , 2014, 395(9): 991-1001.
[51] Poliseno L, Haimovic A, Christos PJ, Vega YSDMEC, Shapiro R, Pavlick A, Berman RS, Darvishian F, Osman I. Deletion of PTENP1 pseudogene in human melanoma. J Invest Dermatol , 2011, 131(12): 2497-2500.
[52] Liu L, Liu Y, Liu JB, Zhai XJ, Wen J, Xie KP, Shen HB, Hu ZB, Fan ZN. Genetic variants in pseudogene E2F3P1 confer risk for HBV-related hepatocellular carcinoma in a Chinese population. J Biomedical Res , 2013, 27(3): 215-219.
[53] Pan Y, Sun CQ, Huang MD, Liu Y, Qi FZ, Liu L, Wen J, Liu JB, Xie KP, Ma HX, Hu ZB, Shen HB. A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinoma. J Biomedical Res , 2014, 28(3): 194-200.
[54] Zhang JY, Wang X, Li MX, Han J, Chen B, Wang B, Dai JW. NANOGP8 is a retrogene expressed in cancers. FEBS J , 2006, 273(8): 1723-1730.
[55] Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, Tang DG. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells , 2009, 27(5): 993-1005.
[56] Bier A, Oviedo-Landaverde I, Zhao J, Mamane Y, Kandouz M, Batist G. Connexin43 pseudogene in breast
cancer cells offers a novel therapeutic target. Mol Cancer Therapeutics , 2009, 8(4): 786-793.
[57] Liu Y, Wang ZQ, Li HM, Wu ZP, Wei F, Wang HP. Role of the ERas gene in gastric cancer cells. Oncol Rep , 2013, 30(1): 50-56.
[58] Piehler AP, Hellum M, Wenzel JJ, Kaminski E, Haug KB, Kierulf P, Kaminski WE. The human ABC transporter pseudogene family: Evidence for transcription and gene-pseudogene interference. BMC Genomics , 2008, 9: 165.
[59] Zou M, Baitei EY, Alzahrani AS, Al-Mohanna F, Farid NR, Meyer B, Shi Y. Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors. Neoplasia , 2009, 11(1): 57-65.
[60] Weakley SM, Wang H, Yao QZ, Chen CY. Expression and function of a large non-coding RNA gene XIST in human cancer. World J Surg , 2011, 35(8): 1751-1756.
[61] Duret L, Chureau C, Samain S, Weissenbach J, Avner P. The Xist RNA gene evolved in eutherians by pseudogenization of a protein-coding gene. Science , 2006, 312(5780): 1653-1655.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

假基因的功能及其在癌症疾病中的重要作用

Functional roles of pseudogenes in cancers

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	梁文权,侯豫,赵存友. 精神分裂症相关单核苷酸多态性调控microRNA功能研究进展[J]. 遗传, 2019, 41(8): 677-685.
[2]	宋亚坤,张敏,王翘楚,彭玉荔,贾方兴,余春红. 利用RNA干扰技术沉默基因表达在本科实验教学中的设计与实践[J]. 遗传, 2019, 41(7): 653-661.
[3]	张競文,续倩,李国亮. 癌症发生发展中的表观遗传学研究[J]. 遗传, 2019, 41(7): 567-581.
[4]	吴志强, 米泽云. 超级增强子在肿瘤研究中的进展[J]. 遗传, 2019, 41(1): 41-51.
[5]	刘启鹏, 安妮, 岑山, 李晓宇. piRNA抑制基因转座的分子机制[J]. 遗传, 2018, 40(6): 445-450.
[6]	胡立桥,周兆才,田伟. Hippo信号通路结构生物学研究进展[J]. 遗传, 2017, 39(7): 659-674.
[7]	许崇凤,段子渊. 中华民族永生细胞库在生命科学研究中的支撑作用[J]. 遗传, 2017, 39(1): 75-86.
[8]	王大勇, 马宁, 惠洋, 高旭. CRISPR/Cas9基因组编辑技术在癌症研究中的应用[J]. 遗传, 2016, 38(1): 1-8.
[9]	周学, 杜宜兰, 金萍, 马飞. 癌症相关microRNA与靶基因的生物信息学分析[J]. 遗传, 2015, 37(9): 855-864.
[10]	李静秋, 杨杰, 周平, 乐燕萍, 龚朝辉. 竞争性内源RNA的生物学功能及其调控[J]. 遗传, 2015, 37(8): 756-764.
[11]	白玉, 陆雯芸, 韩凝, 边红武, 朱睦元. miR126功能的多效性与先天性免疫[J]. 遗传, 2014, 36(7): 631-636.
[12]	樊春燕, 魏强, 郝志强, 李广林. miRNAs调控lincRNAs的生物信息学预测与功能分析[J]. 遗传, 2014, 36(12): 1226-1234.
[13]	张凡，林爱华，林美华，丁元林，饶绍奇. 基于双聚类挖掘癌症共享的基因功能模块[J]. 遗传, 2013, 35(3): 333-342.
[14]	何苗，王子卫. miRNA与siRNA胃癌相关研究的现状及进展[J]. 遗传, 2011, 33(9): 925-930.
[15]	周志军，张艳霞，常岩林，杨明茹. 暗褐蝈螽不同地理种群间的遗传分化[J]. 遗传, 2011, 33(1): 75-80.